Pancreatic Adenocarcinoma Metastatic Completed Phase 1 / 2 Trials for Oxaliplatin (DB00526)

Also known as: Metastatic Pancreatic Adenocarcinoma / Pancreatic carcinoma metastatic

IndicationStatusPhase
DBCOND0060224 (Pancreatic Adenocarcinoma Metastatic)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01415713The Study of Metastatic Pancreatic AdenocarcinomaTreatment